Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
weight-loss and diet control industry
weight-loss and diet control industry
Page 3 of 10
Leadership
Billionaire investor John Paulson shies away from Trump’s Treasury due to ‘complex financial obligations’
By
Sydney Lake
November 12, 2024
Lifestyle
Danish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness
By
Ryan Hogg
November 4, 2024
Health
Novo’s main Ozempic plant cited for quality lapses by FDA
By
Madison Muller
and
Bloomberg
October 29, 2024
Health
Companies are more willing to consider covering weight-loss drugs
By
Chris Morris
October 10, 2024
Health
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
By
Lindsey Leake
October 10, 2024
Health
Ozempic may help manage opioid addiction: study
By
Naomi Kresge
and
Bloomberg
September 25, 2024
Health
Elon Musk and Bernie Sanders say they agree on one thing—cheaper Ozempic
By
Christiaan Hetzner
September 25, 2024
Politics
Bernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By
Madison Muller
,
Naomi Kresge
,
Riley Griffin
and
Bloomberg
September 24, 2024
Health
Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By
Ryan Hogg
September 24, 2024
Finance
Obesity drugmaker BioAge targets $158 million in IPO
By
David Morris
and
Bloomberg
September 18, 2024
Finance
Ozempic ‘very likely’ to have price slashed in US government negotiations
By
Gerry Smith
,
Madison Muller
and
Bloomberg
September 17, 2024
Retail
Secondhand luxury fashion thrives as Ozempic users purge their closets
By
Sasha Rogelberg
August 29, 2024
Health
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By
Alexa Mikhail
August 14, 2024
Commentary
Here’s the real reason Ozempic-like weight-loss drugs are so popular
By
Bill Novelli
August 12, 2024
Life
How intermittent fasting could help boost your work performance
By
Sonya Collins
August 11, 2024
Most Popular
Politics
The White House has faced a flurry of rejections after inviting 9 universities to be the first signatories of its...
By
Collin Binkley
,
Jonathan Mattise
, and others
Economy
S&P analysis of 9,000 companies worldwide finds the real cost of tariffs and other corporate costs: $1.2 trillion
By
Nino Paoli
Success
CEO of $8 billion AI company says it’s ‘mind-boggling’ that people think you can work 38 hours a week, have work-life...
By
Emma Burleigh